Crose LE - Search Results

1

Alveolar rhabdomyosarcoma-associated PAX3-FOXO1 promotes tumorigenesis via Hippo pathway suppression.

Crose LE, Galindo KA, Kephart JG, Chen C, Fitamant J, Bardeesy N, Bentley RC, Galindo RL, Chi JT, Linardic CM. Crose LE, et al. J Clin Invest. 2014 Jan;124(1):285-96. doi: 10.1172/JCI67087. Epub 2013 Dec 16. J Clin Invest. 2014. PMID: 24334454 Free PMC article.

2

FGFR4 blockade exerts distinct antitumorigenic effects in human embryonal versus alveolar rhabdomyosarcoma.

Crose LE, Etheridge KT, Chen C, Belyea B, Talbot LJ, Bentley RC, Linardic CM. Crose LE, et al. Clin Cancer Res. 2012 Jul 15;18(14):3780-90. doi: 10.1158/1078-0432.CCR-10-3063. Epub 2012 May 30. Clin Cancer Res. 2012. PMID: 22648271 Free PMC article.

3

Secreted Frizzled-Related Protein 3 (SFRP3) Is Required for Tumorigenesis of PAX3-FOXO1-Positive Alveolar Rhabdomyosarcoma.

Kephart JJ, Tiller RG, Crose LE, Slemmons KK, Chen PH, Hinson AR, Bentley RC, Chi JT, Linardic CM. Kephart JJ, et al. Among authors: crose le. Clin Cancer Res. 2015 Nov 1;21(21):4868-80. doi: 10.1158/1078-0432.CCR-14-1797. Epub 2015 Jun 12. Clin Cancer Res. 2015. PMID: 26071485 Free PMC article.

4

Role of the YAP Oncoprotein in Priming Ras-Driven Rhabdomyosarcoma.

Slemmons KK, Crose LE, Rudzinski E, Bentley RC, Linardic CM. Slemmons KK, et al. Among authors: crose le. PLoS One. 2015 Oct 23;10(10):e0140781. doi: 10.1371/journal.pone.0140781. eCollection 2015. PLoS One. 2015. PMID: 26496700 Free PMC article.

5

The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis.

Deel MD, Slemmons KK, Hinson AR, Genadry KC, Burgess BA, Crose LES, Kuprasertkul N, Oristian KM, Bentley RC, Linardic CM. Deel MD, et al. Among authors: crose les. Clin Cancer Res. 2018 Jun 1;24(11):2616-2630. doi: 10.1158/1078-0432.CCR-17-1207. Epub 2018 Mar 7. Clin Cancer Res. 2018. PMID: 29514840 Free PMC article.

6

Loss of MST/Hippo Signaling in a Genetically Engineered Mouse Model of Fusion-Positive Rhabdomyosarcoma Accelerates Tumorigenesis.

Oristian KM, Crose LES, Kuprasertkul N, Bentley RC, Lin YT, Williams N, Kirsch DG, Linardic CM. Oristian KM, et al. Among authors: crose les. Cancer Res. 2018 Oct 1;78(19):5513-5520. doi: 10.1158/0008-5472.CAN-17-3912. Epub 2018 Aug 9. Cancer Res. 2018. PMID: 30093562 Free PMC article.

7

A Novel Notch-YAP Circuit Drives Stemness and Tumorigenesis in Embryonal Rhabdomyosarcoma.

Slemmons KK, Crose LES, Riedel S, Sushnitha M, Belyea B, Linardic CM. Slemmons KK, et al. Among authors: crose les. Mol Cancer Res. 2017 Dec;15(12):1777-1791. doi: 10.1158/1541-7786.MCR-17-0004. Epub 2017 Sep 18. Mol Cancer Res. 2017. PMID: 28923841 Free PMC article.

8

Receptor tyrosine kinases as therapeutic targets in rhabdomyosarcoma.

Crose LE, Linardic CM. Crose LE, et al. Sarcoma. 2011;2011:756982. doi: 10.1155/2011/756982. Epub 2011 Jan 2. Sarcoma. 2011. PMID: 21253475 Free PMC article.

9

Histone Deacetylase Inhibitors Inhibit Rhabdomyosarcoma by Reactive Oxygen Species-Dependent Targeting of Specificity Protein Transcription Factors.

Hedrick E, Crose L, Linardic CM, Safe S. Hedrick E, et al. Mol Cancer Ther. 2015 Sep;14(9):2143-53. doi: 10.1158/1535-7163.MCT-15-0148. Epub 2015 Jul 10. Mol Cancer Ther. 2015. PMID: 26162688 Free PMC article.

10

Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors.

Chadalapaka G, Jutooru I, Sreevalsan S, Pathi S, Kim K, Chen C, Crose L, Linardic C, Safe S. Chadalapaka G, et al. Int J Cancer. 2013 Feb 15;132(4):795-806. doi: 10.1002/ijc.27730. Epub 2012 Aug 3. Int J Cancer. 2013. PMID: 22815231 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters